{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:39:21Z","timestamp":1790627961832,"version":"4.1.0"},"publisher-location":"New York, NY","reference-count":132,"publisher":"Springer US","isbn-type":[{"value":"9781493998487","type":"print"},{"value":"9781493998494","type":"electronic"}],"license":[{"start":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T00:00:00Z","timestamp":1568592000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1007\/978-1-4939-9849-4_16","type":"book-chapter","created":{"date-parts":[[2019,9,15]],"date-time":"2019-09-15T11:03:46Z","timestamp":1568545426000},"page":"229-251","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":82,"title":["Methicillin-Resistant Staphylococcus aureus Infection and Treatment Options"],"prefix":"10.1007","author":[{"given":"Sarah J.","family":"Chalmers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark E.","family":"Wylam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,16]]},"reference":[{"issue":"1054","key":"16_CR1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.1054.369","volume":"1","author":"A Ogston","year":"1881","unstructured":"Ogston A (1881) Report upon micro-organisms in surgical diseases. Br Med J 1(1054):369.b2\u2013375","journal-title":"Br Med J"},{"issue":"2","key":"16_CR2","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1128\/IAI.70.2.631-641.2002","volume":"70","author":"S Jarraud","year":"2002","unstructured":"Jarraud S, Mougel C, Thioulouse J, Lina G, Meugnier H, Forey F et al (2002) Relationships between Staphylococcus aureus genetic background, virulence factors, agr groups (alleles), and human disease. Infect Immun 70(2):631\u2013641","journal-title":"Infect Immun"},{"key":"16_CR3","doi-asserted-by":"publisher","first-page":"18033","DOI":"10.1038\/nrdp.2018.33","volume":"4","author":"AS Lee","year":"2018","unstructured":"Lee AS, de Lencastre H, Garau J, Kluytmans J, Malhotra-Kumar S, Peschel A et al (2018) Methicillin-resistant Staphylococcus aureus. Nat Rev Dis Primers 4:18033","journal-title":"Nat Rev Dis Primers"},{"issue":"8","key":"16_CR4","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1086\/592051","volume":"198","author":"B Shopsin","year":"2008","unstructured":"Shopsin B, Drlica-Wagner A, Mathema B, Adhikari RP, Kreiswirth BN, Novick RP (2008) Prevalence of agr dysfunction among colonizing Staphylococcus aureus strains. J Infect Dis 198(8):1171\u20131174","journal-title":"J Infect Dis"},{"issue":"8","key":"16_CR5","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1093\/infdis\/jis483","volume":"206","author":"DS Smyth","year":"2012","unstructured":"Smyth DS, Kafer JM, Wasserman GA, Velickovic L, Mathema B, Holzman RS et al (2012) Nasal carriage as a source of agr-defective Staphylococcus aureus bacteremia. J Infect Dis 206(8):1168\u20131177","journal-title":"J Infect Dis"},{"issue":"12","key":"16_CR6","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.tim.2014.09.002","volume":"22","author":"KL Painter","year":"2014","unstructured":"Painter KL, Krishna A, Wigneshweraraj S, Edwards AM (2014) What role does the quorum-sensing accessory gene regulator system play during Staphylococcus aureus bacteremia? Trends Microbiol 22(12):676\u2013685","journal-title":"Trends Microbiol"},{"key":"16_CR7","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s13059-017-1252-9","volume":"18","author":"CP Harkins","year":"2017","unstructured":"Harkins CP, Pichon B, Doumith M, Parkhill J, Westh H, Tomasz A et al (2017) Methicillin-resistant Staphylococcus aureus emerged long before the introduction of methicillin into clinical practice. Genome Biol 18:130","journal-title":"Genome Biol"},{"issue":"5219","key":"16_CR8","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1136\/bmj.1.5219.124-a","volume":"1","author":"MP Jevons","year":"1961","unstructured":"Jevons MP (1961) \u201cClabbering\u201d \u2013 resistant Staphylococci. Br Med J 1(5219):124\u2013125","journal-title":"Br Med J"},{"issue":"Suppl 2","key":"16_CR9","doi-asserted-by":"publisher","first-page":"S114","DOI":"10.1086\/320184","volume":"32","author":"DJ Diekema","year":"2001","unstructured":"Diekema DJ, Pfaller MA, Schmitz FJ, Smayevsky J, Bell J, Jones RN et al (2001) Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997\u20131999. Clin Infect Dis 32(Suppl 2):S114\u2013S132","journal-title":"Clin Infect Dis"},{"key":"16_CR10","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1476-0711-5-2","volume":"5","author":"D Styers","year":"2006","unstructured":"Styers D, Sheehan DJ, Hogan P, Sahm DF (2006) Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States. Ann Clin Microbiol Antimicrob 5:2","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"16_CR11","unstructured":"Prevention CfDCa (2012) Active bacterial core surveillance report, Emerging Infections Program Network, Methicillin-Resistant Staphylococcus aureus, 2011. \n                  http:\/\/www.cdc.gov\/abcs\/reports-findings\/survreports\/mrsa11.pdf\n                  \n                ."},{"issue":"Suppl 2","key":"16_CR12","doi-asserted-by":"publisher","first-page":"S108","DOI":"10.1017\/S0899823X00193882","volume":"35","author":"DP Calfee","year":"2014","unstructured":"Calfee DP, Salgado CD, Milstone AM, Harris AD, Kuhar DT, Moody J et al (2014) Strategies to prevent methicillin-resistant Staphylococcus aureus transmission and infection in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol 35(Suppl 2):S108\u2013S132","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"15","key":"16_CR13","first-page":"1470","volume":"369","author":"SS Huang","year":"2013","unstructured":"Huang SS, Septimus E, Platt R (2013) Targeted decolonization to prevent ICU infections. N Engl J Med 369(15):1470\u20131471","journal-title":"N Engl J Med"},{"issue":"2","key":"16_CR14","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1089\/107662903765826741","volume":"9","author":"GR Nimmo","year":"2003","unstructured":"Nimmo GR, Bell JM, Mitchell D, Gosbell IB, Pearman JW, Turnidge JD et al (2003) Antimicrobial resistance in Staphylococcus aureus in Australian teaching hospitals, 1989\u20131999. Microb Drug Resist 9(2):155\u2013160","journal-title":"Microb Drug Resist"},{"issue":"2","key":"16_CR15","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jhin.2005.07.011","volume":"62","author":"MA Morrison","year":"2006","unstructured":"Morrison MA, Hageman JC, Klevens RM (2006) Case definition for community-associated methicillin-resistant Staphylococcus aureus. J Hosp Infect 62(2):241","journal-title":"J Hosp Infect"},{"issue":"4","key":"16_CR16","doi-asserted-by":"publisher","first-page":"521","DOI":"10.3390\/antibiotics4040521","volume":"4","author":"C Cuny","year":"2015","unstructured":"Cuny C, Wieler LH, Witte W (2015) Livestock-associated MRSA: the impact on humans. Antibiotics (Basel) 4(4):521\u2013543","journal-title":"Antibiotics (Basel)"},{"issue":"6\u20137","key":"16_CR17","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.ijmm.2013.02.010","volume":"303","author":"C Cuny","year":"2013","unstructured":"Cuny C, Kock R, Witte W (2013) Livestock associated MRSA (LA-MRSA) and its relevance for humans in Germany. Int J Med Microbiol 303(6\u20137):331\u2013337","journal-title":"Int J Med Microbiol"},{"issue":"9","key":"16_CR18","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/nrmicro2200","volume":"7","author":"HF Chambers","year":"2009","unstructured":"Chambers HF, Deleo FR (2009) Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat Rev Microbiol 7(9):629\u2013641","journal-title":"Nat Rev Microbiol"},{"issue":"2","key":"16_CR19","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jgar.2014.02.003","volume":"2","author":"SM Purrello","year":"2014","unstructured":"Purrello SM, Daum RS, Edwards GFS, Lina G, Lindsay J, Peters G et al (2014) Meticillin-resistant Staphylococcus aureus (MRSA) update: new insights into bacterial adaptation and therapeutic targets. J Glob Antimicrob Resist 2(2):61\u201369","journal-title":"J Glob Antimicrob Resist"},{"issue":"4","key":"16_CR20","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1089\/mdr.1996.2.435","volume":"2","author":"S Wu","year":"1996","unstructured":"Wu S, Piscitelli C, de Lencastre H, Tomasz A (1996) Tracking the evolutionary origin of the methicillin resistance gene: cloning and sequencing of a homologue of mecA from a methicillin susceptible strain of Staphylococcus sciuri. Microb Drug Resist 2(4):435\u2013441","journal-title":"Microb Drug Resist"},{"issue":"8","key":"16_CR21","doi-asserted-by":"publisher","first-page":"3765","DOI":"10.1128\/AAC.00187-11","volume":"55","author":"AC Shore","year":"2011","unstructured":"Shore AC, Deasy EC, Slickers P, Brennan G, O'Connell B, Monecke S et al (2011) Detection of staphylococcal cassette chromosome mec type XI carrying highly divergent mecA, mecI, mecR1, blaZ, and ccr genes in human clinical isolates of clonal complex 130 methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 55(8):3765\u20133773","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"16_CR22","doi-asserted-by":"publisher","first-page":"3046","DOI":"10.1128\/AAC.01475-10","volume":"55","author":"S Li","year":"2011","unstructured":"Li S, Skov RL, Han X, Larsen AR, Larsen J, Sorum M et al (2011) Novel types of staphylococcal cassette chromosome mec elements identified in clonal complex 398 methicillin-resistant Staphylococcus aureus strains. Antimicrob Agents Chemother 55(6):3046\u20133050","journal-title":"Antimicrob Agents Chemother"},{"key":"16_CR23","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jgar.2016.04.004","volume":"6","author":"AM Bal","year":"2016","unstructured":"Bal AM, Coombs GW, Holden MTG, Lindsay JA, Nimmo GR, Tattevin P et al (2016) Genomic insights into the emergence and spread of international clones of healthcare-, community- and livestock-associated meticillin-resistant Staphylococcus aureus: blurring of the traditional definitions. J Glob Antimicrob Resist 6:95\u2013101","journal-title":"J Glob Antimicrob Resist"},{"issue":"11","key":"16_CR24","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/BF01967563","volume":"8","author":"PE Reynolds","year":"1989","unstructured":"Reynolds PE (1989) Structure, biochemistry and mechanism of action of glycopeptide antibiotics. Eur J Clin Microbiol Infect Dis 8(11):943\u2013950","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"16_CR25","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1093\/jac\/40.1.135","volume":"40","author":"K Hiramatsu","year":"1997","unstructured":"Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC (1997) Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 40(1):135\u2013136","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"16_CR26","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1172\/JCI68834","volume":"124","author":"S Gardete","year":"2014","unstructured":"Gardete S, Tomasz A (2014) Mechanisms of vancomycin resistance in Staphylococcus aureus. J Clin Invest 124(7):2836\u20132840","journal-title":"J Clin Invest"},{"issue":"5","key":"16_CR27","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1086\/527392","volume":"46","author":"DM Sievert","year":"2008","unstructured":"Sievert DM, Rudrik JT, Patel JB, McDonald LC, Wilkins MJ, Hageman JC (2008) Vancomycin-resistant Staphylococcus aureus in the United States, 2002\u20132006. Clin Infect Dis 46(5):668\u2013674","journal-title":"Clin Infect Dis"},{"issue":"14","key":"16_CR28","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1056\/NEJMoa025025","volume":"348","author":"S Chang","year":"2003","unstructured":"Chang S, Sievert DM, Hageman JC, Boulton ML, Tenover FC, Downes FP et al (2003) Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med 348(14):1342\u20131347","journal-title":"N Engl J Med"},{"issue":"8","key":"16_CR29","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.micinf.2008.04.018","volume":"10","author":"C Berglund","year":"2008","unstructured":"Berglund C, Prevost G, Laventie BJ, Keller D, Soderquist B (2008) The genes for Panton Valentine Leukocidin (PVL) are conserved in diverse lines of methicillin-resistant and methicillin-susceptible Staphylococcus aureus. Microbes Infect 10(8):878\u2013884","journal-title":"Microbes Infect"},{"issue":"3","key":"16_CR30","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1128\/CMR.10.3.505","volume":"10","author":"J Kluytmans","year":"1997","unstructured":"Kluytmans J, van Belkum A, Verbrugh H (1997) Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 10(3):505\u2013520","journal-title":"Clin Microbiol Rev"},{"issue":"6","key":"16_CR31","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1055\/s-0036-1593753","volume":"37","author":"RG Wunderink","year":"2016","unstructured":"Wunderink RG, Yin Y (2016) Antibiotic resistance in community-acquired pneumonia pathogens. Semin Respir Crit Care Med 37(6):829\u2013838","journal-title":"Semin Respir Crit Care Med"},{"issue":"2","key":"16_CR32","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1086\/499632","volume":"193","author":"MJ Kuehnert","year":"2006","unstructured":"Kuehnert MJ, Kruszon-Moran D, Hill HA, McQuillan G, McAllister SK, Fosheim G et al (2006) Prevalence of Staphylococcus aureus nasal colonization in the United States, 2001\u20132002. J Infect Dis 193(2):172\u2013179","journal-title":"J Infect Dis"},{"issue":"1","key":"16_CR33","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1017\/S0950268800058118","volume":"115","author":"NH Eriksen","year":"1995","unstructured":"Eriksen NH, Espersen F, Rosdahl VT, Jensen K (1995) Carriage of Staphylococcus aureus among 104 healthy persons during a 19-month period. Epidemiol Infect 115(1):51\u201360","journal-title":"Epidemiol Infect"},{"issue":"5","key":"16_CR34","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.ajic.2012.07.017","volume":"41","author":"E Stenehjem","year":"2013","unstructured":"Stenehjem E, Rimland D (2013) MRSA nasal colonization burden and risk of MRSA infection. Am J Infect Control 41(5):405\u2013410","journal-title":"Am J Infect Control"},{"issue":"1","key":"16_CR35","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJM200101043440102","volume":"344","author":"C Eiff von","year":"2001","unstructured":"von Eiff C, Becker K, Machka K, Stammer H, Peters G (2001) Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group. N Engl J Med 344(1):11\u201316","journal-title":"N Engl J Med"},{"issue":"3","key":"16_CR36","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.ajic.2012.02.001","volume":"40","author":"WR Jarvis","year":"2012","unstructured":"Jarvis WR, Jarvis AA, Chinn RY (2012) National prevalence of methicillin-resistant Staphylococcus aureus in inpatients at United States health care facilities, 2010. Am J Infect Control 40(3):194\u2013200","journal-title":"Am J Infect Control"},{"key":"16_CR37","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.2147\/IDR.S170497","volume":"11","author":"G Xiao","year":"2018","unstructured":"Xiao G, Chen Z, Lv X (2018) Chlorhexidine-based body washing for colonization and infection of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus: an updated meta-analysis. Infect Drug Resist 11:1473\u20131481","journal-title":"Infect Drug Resist"},{"issue":"9","key":"16_CR38","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1086\/533501","volume":"197","author":"M Emonts","year":"2008","unstructured":"Emonts M, Uitterlinden AG, Nouwen JL, Kardys I, Maat MP, Melles DC et al (2008) Host polymorphisms in interleukin 4, complement factor H, and C-reactive protein associated with nasal carriage of Staphylococcus aureus and occurrence of boils. J Infect Dis 197(9):1244\u20131253","journal-title":"J Infect Dis"},{"key":"16_CR39","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/nrmicro.2017.104","volume":"15","author":"B Krismer","year":"2017","unstructured":"Krismer B, Weidenmaier C, Zipperer A, Peschel A (2017) The commensal lifestyle of Staphylococcus aureus and its interactions with the nasal microbiota. Nat Rev Microbiol 15:675","journal-title":"Nat Rev Microbiol"},{"issue":"2","key":"16_CR40","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1053\/jhin.1999.0680","volume":"44","author":"Y Uehara","year":"2000","unstructured":"Uehara Y, Nakama H, Agematsu K, Uchida M, Kawakami Y, Abdul Fattah AS et al (2000) Bacterial interference among nasal inhabitants: eradication of Staphylococcus aureus from nasal cavities by artificial implantation of Corynebacterium sp. J Hosp Infect 44(2):127\u2013133","journal-title":"J Hosp Infect"},{"key":"16_CR41","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13756-015-0096-x","volume":"4","author":"N Sai","year":"2015","unstructured":"Sai N, Laurent C, Strale H, Denis O, Byl B (2015) Efficacy of the decolonization of methicillin-resistant Staphylococcus aureus carriers in clinical practice. Antimicrob Resist Infect Control 4:56","journal-title":"Antimicrob Resist Infect Control"},{"issue":"1","key":"16_CR42","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1001\/archpedi.1972.02110070095012","volume":"123","author":"PW Houck","year":"1972","unstructured":"Houck PW, Nelson JD, Kay JL (1972) Fatal septicemia due to Staphylococcus aureus 502A. Report of a case and review of the infectious complications of bacterial interference programs. Am J Dis Child 123(1):45\u201348","journal-title":"Am J Dis Child"},{"key":"16_CR43","volume":"4","author":"M Rijen van","year":"2008","unstructured":"van Rijen M, Bonten M, Wenzel R, Kluytmans J (2008) Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers. Cochrane Database Syst Rev 4:Cd006216","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"16_CR44","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1001\/archsurg.1937.01190110117007","volume":"34","author":"D Hart","year":"1937","unstructured":"Hart D (1937) Operation room infections: control of air-borne pathogenic organisms, with particular reference to the use of special bactericidal radiant energy; preliminary report. Arch Surg 34(5):874\u2013896","journal-title":"Arch Surg"},{"issue":"5","key":"16_CR45","doi-asserted-by":"publisher","first-page":"789","DOI":"10.3181\/00379727-36-9400","volume":"36","author":"FA Hallman","year":"1937","unstructured":"Hallman FA (1937) Pathogenic staphylococci in the anterior nares: their incidence and differentiation. Proc Soc Exp Biol Med 36(5):789\u2013794","journal-title":"Proc Soc Exp Biol Med"},{"issue":"2","key":"16_CR46","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1086\/669095","volume":"34","author":"JA McKinnell","year":"2013","unstructured":"McKinnell JA, Huang SS, Eells SJ, Cui E, Miller LG (2013) Quantifying the impact of extranasal testing of body sites for methicillin-resistant Staphylococcus aureus colonization at the time of hospital or intensive care unit admission. Infect Control Hosp Epidemiol 34(2):161\u2013170","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"2","key":"16_CR47","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jhin.2017.10.016","volume":"98","author":"TT Poovelikunnel","year":"2018","unstructured":"Poovelikunnel TT, Gethin G, Solanki D, McFadden E, Codd M, Humphreys H (2018) Randomized controlled trial of honey versus mupirocin to decolonize patients with nasal colonization of meticillin-resistant Staphylococcus aureus. J Hosp Infect 98(2):141\u2013148","journal-title":"J Hosp Infect"},{"issue":"1","key":"16_CR48","doi-asserted-by":"publisher","first-page":"8","DOI":"10.4037\/ajcc2015102","volume":"24","author":"B Tilahun","year":"2015","unstructured":"Tilahun B, Faust AC, McCorstin P, Ortegon A (2015) Nasal colonization and lower respiratory tract infections with methicillin-resistant Staphylococcus aureus. Am J Crit Care 24(1):8\u201312","journal-title":"Am J Crit Care"},{"key":"16_CR49","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1001\/archpedi.1964.02090010254006","volume":"108","author":"M Boris","year":"1964","unstructured":"Boris M, Sellers TF Jr, Eichenwald HF, Ribble JC, Shinefield HR (1964) Bacterial interference; protection of adults against nasal Staphylococcus aureus infection after colonization with a heterologous S aureus strain. Am J Dis Child 108:252\u2013261","journal-title":"Am J Dis Child"},{"issue":"1","key":"16_CR50","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12890-018-0588-6","volume":"18","author":"A Kiefer","year":"2018","unstructured":"Kiefer A, Bogdan C, Melichar VO (2018) Successful eradication of newly acquired MRSA in six of seven patients with cystic fibrosis applying a short-term local and systemic antibiotic scheme. BMC Pulm Med 18(1):20","journal-title":"BMC Pulm Med"},{"issue":"5","key":"16_CR51","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1097\/CCM.0b013e318243168e","volume":"40","author":"JD Chan","year":"2012","unstructured":"Chan JD, Dellit TH, Choudhuri JA, McNamara E, Melius EJ, Evans HL et al (2012) Active surveillance cultures of methicillin-resistant Staphylococcus aureus as a tool to predict methicillin-resistant S. aureus ventilator-associated pneumonia. Crit Care Med 40(5):1437\u20131442","journal-title":"Crit Care Med"},{"issue":"9","key":"16_CR52","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.ajic.2014.05.026","volume":"42","author":"J Langsjoen","year":"2014","unstructured":"Langsjoen J, Brady C, Obenauf E, Kellie S (2014) Nasal screening is useful in excluding methicillin-resistant Staphylococcus aureus in ventilator-associated pneumonia. Am J Infect Control 42(9):1014\u20131015","journal-title":"Am J Infect Control"},{"key":"16_CR53","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1002\/phar.2188","volume":"38","author":"AL Carr","year":"2018","unstructured":"Carr AL, Daley MJ, Givens Merkel K, Rose DT (2018) Clinical utility of methicillin-resistant Staphylococcus aureus nasal screening for antimicrobial stewardship: a review of current literature. Pharmacotherapy 38:1216","journal-title":"Pharmacotherapy"},{"issue":"10","key":"16_CR54","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.ajic.2017.04.011","volume":"45","author":"C Acuna-Villaorduna","year":"2017","unstructured":"Acuna-Villaorduna C, Branch-Elliman W, Strymish J, Gupta K (2017) Active identification of patients who are methicillin-resistant Staphylococcus aureus colonized is not associated with longer duration of vancomycin therapy. Am J Infect Control 45(10):1081\u20131085","journal-title":"Am J Infect Control"},{"issue":"10","key":"16_CR55","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1097\/CCM.0b013e3181eeda3f","volume":"38","author":"KV Sarikonda","year":"2010","unstructured":"Sarikonda KV, Micek ST, Doherty JA, Reichley RM, Warren D, Kollef MH (2010) Methicillin-resistant Staphylococcus aureus nasal colonization is a poor predictor of intensive care unit-acquired methicillin-resistant Staphylococcus aureus infections requiring antibiotic treatment. Crit Care Med 38(10):1991\u20131995","journal-title":"Crit Care Med"},{"issue":"6","key":"16_CR56","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1093\/jac\/dkn373","volume":"62","author":"IF Chaberny","year":"2008","unstructured":"Chaberny IF, Schwab F, Ziesing S, Suerbaum S, Gastmeier P (2008) Impact of routine surgical ward and intensive care unit admission surveillance cultures on hospital-wide nosocomial methicillin-resistant Staphylococcus aureus infections in a university hospital: an interrupted time-series analysis. J Antimicrob Chemother 62(6):1422\u20131429","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"16_CR57","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1086\/507915","volume":"27","author":"M Clancy","year":"2006","unstructured":"Clancy M, Graepler A, Wilson M, Douglas I, Johnson J, Price CS (2006) Active screening in high-risk units is an effective and cost-avoidant method to reduce the rate of methicillin-resistant Staphylococcus aureus infection in the hospital. Infect Control Hosp Epidemiol 27(10):1009\u20131017","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"6","key":"16_CR58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0099192","volume":"9","author":"HC Jang","year":"2014","unstructured":"Jang HC, Choi OJ, Kim GS, Jang MO, Kang SJ, Jung SI et al (2014) Active surveillance of the trachea or throat for MRSA is more sensitive than nasal surveillance and a better predictor of MRSA infections among patients in intensive care. PLoS One 9(6):e99192","journal-title":"PLoS One"},{"issue":"3","key":"16_CR59","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1097\/MCP.0000000000000367","volume":"23","author":"ML Metersky","year":"2017","unstructured":"Metersky ML, Kalil AC (2017) New guidelines for nosocomial pneumonia. Curr Opin Pulm Med 23(3):211\u2013217","journal-title":"Curr Opin Pulm Med"},{"issue":"1","key":"16_CR60","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1093\/cid\/civ777","volume":"62","author":"L Epstein","year":"2016","unstructured":"Epstein L, Mu Y, Belflower R, Scott J, Ray S, Dumyati G et al (2016) Risk factors for invasive methicillin-resistant Staphylococcus aureus infection after recent discharge from an acute-care hospitalization, 2011\u20132013. Clin Infect Dis 62(1):45\u201352","journal-title":"Clin Infect Dis"},{"issue":"5","key":"16_CR61","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1093\/cid\/ciw504","volume":"63","author":"AC Kalil","year":"2016","unstructured":"Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, Palmer LB et al (2016) Executive summary: management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis 63(5):575\u2013582","journal-title":"Clin Infect Dis"},{"key":"16_CR62","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1471-2180-14-31","volume":"14","author":"KY Chua","year":"2014","unstructured":"Chua KY, Monk IR, Lin YH, Seemann T, Tuck KL, Porter JL et al (2014) Hyperexpression of alpha-hemolysin explains enhanced virulence of sequence type 93 community-associated methicillin-resistant Staphylococcus aureus. BMC Microbiol 14:31","journal-title":"BMC Microbiol"},{"issue":"10","key":"16_CR63","doi-asserted-by":"publisher","first-page":"4735","DOI":"10.1128\/JCM.42.10.4735-4743.2004","volume":"42","author":"GW Coombs","year":"2004","unstructured":"Coombs GW, Nimmo GR, Bell JM, Huygens F, O'Brien FG, Malkowski MJ et al (2004) Genetic diversity among community methicillin-resistant Staphylococcus aureus strains causing outpatient infections in Australia. J Clin Microbiol 42(10):4735\u20134743","journal-title":"J Clin Microbiol"},{"issue":"7","key":"16_CR64","doi-asserted-by":"publisher","first-page":"3185","DOI":"10.1128\/JCM.42.7.3185-3190.2004","volume":"42","author":"FG O'Brien","year":"2004","unstructured":"O'Brien FG, Lim TT, Chong FN, Coombs GW, Enright MC, Robinson DA et al (2004) Diversity among community isolates of methicillin-resistant Staphylococcus aureus in Australia. J Clin Microbiol 42(7):3185\u20133190","journal-title":"J Clin Microbiol"},{"issue":"32","key":"16_CR65","first-page":"707","volume":"48","author":"C Hunt","year":"1999","unstructured":"Hunt C (1999) Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus - Minnesota and North Dakota, 1997\u20131999. MMWR Morb Mortal Wkly Rep 48(32):707\u2013710","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"8","key":"16_CR66","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1001\/jama.279.8.593","volume":"279","author":"BC Herold","year":"1998","unstructured":"Herold BC, Immergluck LC, Maranan MC, Lauderdale DS, Gaskin RE, Boyle-Vavra S et al (1998) Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 279(8):593\u2013598","journal-title":"JAMA"},{"issue":"10","key":"16_CR67","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1111\/j.1462-5822.2012.01832.x","volume":"14","author":"M Otto","year":"2012","unstructured":"Otto M (2012) MRSA virulence and spread. Cell Microbiol 14(10):1513\u20131521","journal-title":"Cell Microbiol"},{"issue":"9308","key":"16_CR68","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/S0140-6736(02)07877-7","volume":"359","author":"Y Gillet","year":"2002","unstructured":"Gillet Y, Issartel B, Vanhems P, Fournet JC, Lina G, Bes M et al (2002) Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 359(9308):753\u2013759","journal-title":"Lancet"},{"issue":"11","key":"16_CR69","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1172\/JCI22684","volume":"115","author":"AL Genestier","year":"2005","unstructured":"Genestier AL, Michallet MC, Prevost G, Bellot G, Chalabreysse L, Peyrol S et al (2005) Staphylococcus aureus Panton-Valentine leukocidin directly targets mitochondria and induces Bax-independent apoptosis of human neutrophils. J Clin Invest 115(11):3117\u20133127","journal-title":"J Clin Invest"},{"issue":"7","key":"16_CR70","doi-asserted-by":"publisher","first-page":"3724","DOI":"10.1128\/IAI.71.7.3724-3729.2003","volume":"71","author":"DA Colin","year":"2003","unstructured":"Colin DA, Monteil H (2003) Control of the oxidative burst of human neutrophils by staphylococcal leukotoxins. Infect Immun 71(7):3724\u20133729","journal-title":"Infect Immun"},{"issue":"3","key":"16_CR71","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1093\/infdis\/171.3.607","volume":"171","author":"B Konig","year":"1995","unstructured":"Konig B, Prevost G, Piemont Y, Konig W (1995) Effects of Staphylococcus aureus leukocidins on inflammatory mediator release from human granulocytes. J Infect Dis 171(3):607\u2013613","journal-title":"J Infect Dis"},{"issue":"3","key":"16_CR72","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1086\/519263","volume":"45","author":"Y Gillet","year":"2007","unstructured":"Gillet Y, Vanhems P, Lina G, Bes M, Vandenesch F, Floret D et al (2007) Factors predicting mortality in necrotizing community-acquired pneumonia caused by Staphylococcus aureus containing Panton-Valentine leukocidin. Clin Infect Dis 45(3):315\u2013321","journal-title":"Clin Infect Dis"},{"issue":"12","key":"16_CR73","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1086\/509506","volume":"194","author":"JM Voyich","year":"2006","unstructured":"Voyich JM, Otto M, Mathema B, Braughton KR, Whitney AR, Welty D et al (2006) Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease? J Infect Dis 194(12):1761\u20131770","journal-title":"J Infect Dis"},{"issue":"8","key":"16_CR74","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1086\/592053","volume":"198","author":"J Bubeck Wardenburg","year":"2008","unstructured":"Bubeck Wardenburg J, Palazzolo-Ballance AM, Otto M, Schneewind O, DeLeo FR (2008) Panton-Valentine leukocidin is not a virulence determinant in murine models of community-associated methicillin-resistant Staphylococcus aureus disease. J Infect Dis 198(8):1166\u20131170","journal-title":"J Infect Dis"},{"issue":"2","key":"16_CR75","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1093\/jac\/dkm206","volume":"60","author":"MJ Ellington","year":"2007","unstructured":"Ellington MJ, Hope R, Ganner M, Ganner M, East C, Brick G, Kearns AM (2007) Is Panton-Valentine leucocidin associated with the pathogenesis of Staphylococcus aureus bacteraemia in the UK? J Antimicrob Chemother 60(2):402\u2013405","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"16_CR76","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S1473-3099(12)70238-4","volume":"13","author":"LJ Shallcross","year":"2013","unstructured":"Shallcross LJ, Fragaszy E, Johnson AM, Hayward AC (2013) The role of the Panton-Valentine leucocidin toxin in staphylococcal disease: a systematic review and meta-analysis. Lancet Infect Dis 13(1):43\u201354","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"16_CR77","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1093\/cid\/cir034","volume":"52","author":"C Liu","year":"2011","unstructured":"Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ et al (2011) Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis 52(3):285\u2013292","journal-title":"Clin Infect Dis"},{"issue":"17","key":"16_CR78","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1001\/archinte.163.17.2066","volume":"163","author":"VG Fowler Jr","year":"2003","unstructured":"Fowler VG Jr, Olsen MK, Corey GR, Woods CW, Cabell CH, Reller LB et al (2003) Clinical identifiers of complicated Staphylococcus aureus bacteremia. Arch Intern Med 163(17):2066\u20132072","journal-title":"Arch Intern Med"},{"issue":"2","key":"16_CR79","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1128\/CMR.05022-11","volume":"25","author":"SJ Hal van","year":"2012","unstructured":"van Hal SJ, Jensen SO, Vaska VL, Espedido BA, Paterson DL, Gosbell IB (2012) Predictors of mortality in Staphylococcus aureus bacteremia. Clin Microbiol Rev 25(2):362\u2013386","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"16_CR80","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1128\/CMR.00134-14","volume":"28","author":"SYC Tong","year":"2015","unstructured":"Tong SYC, Davis JS, Eichenberger E, Holland TL, Fowler VG Jr (2015) Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev 28(3):603\u2013661","journal-title":"Clin Microbiol Rev"},{"issue":"12","key":"16_CR81","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.cmi.2017.04.025","volume":"23","author":"AD Bai","year":"2017","unstructured":"Bai AD, Agarwal A, Steinberg M, Showler A, Burry L, Tomlinson GA et al (2017) Clinical predictors and clinical prediction rules to estimate initial patient risk for infective endocarditis in Staphylococcus aureus bacteraemia: a systematic review and meta-analysis. Clin Microbiol Infect 23(12):900\u2013906","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"16_CR82","doi-asserted-by":"publisher","first-page":"221.e211","DOI":"10.1016\/j.amjmed.2015.09.006","volume":"129","author":"AJ Tande","year":"2016","unstructured":"Tande AJ, Palraj BR, Osmon DR, Berbari EF, Baddour LM, Lohse CM et al (2016) Clinical presentation, risk factors, and outcomes of hematogenous prosthetic joint infection in patients with Staphylococcus aureus bacteremia. Am J Med 129(2):221.e211\u2013221.e220","journal-title":"Am J Med"},{"issue":"2","key":"16_CR83","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.idc.2017.01.010","volume":"31","author":"SK Schmitt","year":"2017","unstructured":"Schmitt SK (2017) Osteomyelitis. Infect Dis Clin N Am 31(2):325\u2013338","journal-title":"Infect Dis Clin N Am"},{"issue":"3","key":"16_CR84","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.jcf.2017.10.008","volume":"17","author":"SL Heltshe","year":"2018","unstructured":"Heltshe SL, Khan U, Beckett V, Baines A, Emerson J, Sanders DB et al (2018) Longitudinal development of initial, chronic and mucoid Pseudomonas aeruginosa infection in young children with cystic fibrosis. J Cyst Fibros 17(3):341\u2013347","journal-title":"J Cyst Fibros"},{"issue":"5","key":"16_CR85","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1093\/cid\/cir399","volume":"53","author":"C Gangell","year":"2011","unstructured":"Gangell C, Gard S, Douglas T, Park J, de Klerk N, Keil T et al (2011) Inflammatory responses to individual microorganisms in the lungs of children with cystic fibrosis. Clin Infect Dis 53(5):425\u2013432","journal-title":"Clin Infect Dis"},{"issue":"5","key":"16_CR86","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s00430-016-0463-0","volume":"205","author":"WK Janhsen","year":"2016","unstructured":"Janhsen WK, Arnold C, Hentschel J, Lehmann T, Pfister W, Baier M et al (2016) Colonization of CF patients\u2019 upper airways with S. aureus contributes more decisively to upper airway inflammation than P. aeruginosa. Med Microbiol Immunol 205(5):485\u2013500","journal-title":"Med Microbiol Immunol"},{"key":"16_CR87","unstructured":"Foundation CF (2017) Cystic Fibrosis Foundation Patient Registry 2016 Annual Data Report. \n                  https:\/\/www.cff.org\/Research\/Researcher-Resources\/Patient-Registry\/2016-Patient-Registry-Annual-Data-Report.pdf\n                  \n                ."},{"key":"16_CR88","unstructured":"Foundation CF (2018) Cystic Fibrosis Foundation Patient Registry 2017 Annual Data Report. Bethesda, MD"},{"issue":"3","key":"16_CR89","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.jcf.2018.07.005","volume":"18","author":"R Dezube","year":"2019","unstructured":"Dezube R, Jennings MT, Rykiel M, Diener-West M, Boyle MP, Chmiel JF et al (2019) Eradication of persistent methicillin-resistant Staphylococcus aureus infection in cystic fibrosis. J Cyst Fibros 18(3):357\u2013363. \n                  https:\/\/doi.org\/10.1016\/j.jcf.2018.07.005","journal-title":"J Cyst Fibros"},{"issue":"5","key":"16_CR90","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.jcf.2011.06.002","volume":"10","author":"CH Goss","year":"2011","unstructured":"Goss CH, Muhlebach MS (2011) Review: Staphylococcus aureus and MRSA in cystic fibrosis. J Cyst Fibros 10(5):298\u2013306","journal-title":"J Cyst Fibros"},{"issue":"23","key":"16_CR91","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1001\/jama.2010.791","volume":"303","author":"EC Dasenbrook","year":"2010","unstructured":"Dasenbrook EC, Checkley W, Merlo CA, Konstan MW, Lechtzin N, Boyle MP (2010) Association between respiratory tract methicillin-resistant Staphylococcus aureus and survival in cystic fibrosis. JAMA 303(23):2386\u20132392","journal-title":"JAMA"},{"issue":"11","key":"16_CR92","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1002\/ppul.20914","volume":"43","author":"GS Sawicki","year":"2008","unstructured":"Sawicki GS, Rasouliyan L, Pasta DJ, Regelmann WE, Wagener JS, Waltz DA et al (2008) The impact of incident methicillin resistant Staphylococcus aureus detection on pulmonary function in cystic fibrosis. Pediatr Pulmonol 43(11):1117\u20131123","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"16_CR93","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jcf.2011.08.006","volume":"11","author":"E Vanderhelst","year":"2012","unstructured":"Vanderhelst E, De Meirleir L, Verbanck S, Pierard D, Vincken W, Malfroot A (2012) Prevalence and impact on FEV(1) decline of chronic methicillin-resistant Staphylococcus aureus (MRSA) colonization in patients with cystic fibrosis. A single-center, case control study of 165 patients. J Cyst Fibros 11(1):2\u20137","journal-title":"J Cyst Fibros"},{"issue":"8","key":"16_CR94","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1164\/rccm.200802-327OC","volume":"178","author":"EC Dasenbrook","year":"2008","unstructured":"Dasenbrook EC, Merlo CA, Diener-West M, Lechtzin N, Boyle MP (2008) Persistent methicillin-resistant Staphylococcus aureus and rate of FEV1 decline in cystic fibrosis. Am J Respir Crit Care Med 178(8):814\u2013821","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"16_CR95","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12890-016-0243-z","volume":"16","author":"ME Wood","year":"2016","unstructured":"Wood ME, Sherrard LJ, Ramsay KA, Yerkovich ST, Reid DW, Kidd TJ et al (2016) Methicillin-resistant Staphylococcus aureus acquisition in healthcare workers with cystic fibrosis: a retrospective cross-sectional study. BMC Pulm Med 16(1):78","journal-title":"BMC Pulm Med"},{"issue":"6","key":"16_CR96","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.jcf.2017.04.010","volume":"16","author":"MT Jennings","year":"2017","unstructured":"Jennings MT, Dasenbrook EC, Lechtzin N, Boyle MP, Merlo CA (2017) Risk factors for persistent methicillin-resistant Staphylococcus aureus infection in cystic fibrosis. J Cyst Fibros 16(6):681\u2013686","journal-title":"J Cyst Fibros"},{"issue":"6","key":"16_CR97","doi-asserted-by":"publisher","first-page":"4079","DOI":"10.1128\/IAI.69.6.4079-4085.2001","volume":"69","author":"SE Cramton","year":"2001","unstructured":"Cramton SE, Ulrich M, Gotz F, Doring G (2001) Anaerobic conditions induce expression of polysaccharide intercellular adhesin in Staphylococcus aureus and Staphylococcus epidermidis. Infect Immun 69(6):4079\u20134085","journal-title":"Infect Immun"},{"issue":"1","key":"16_CR98","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1128\/JCM.01510-06","volume":"45","author":"S Besier","year":"2007","unstructured":"Besier S, Smaczny C, Von Mallinckrodt C, Krahl A, Ackermann H, Brade V et al (2007) Prevalence and clinical significance of Staphylococcus aureus small-colony variants in cystic fibrosis lung disease. J Clin Microbiol 45(1):168\u2013172","journal-title":"J Clin Microbiol"},{"issue":"4","key":"16_CR99","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1086\/515238","volume":"177","author":"B Kahl","year":"1998","unstructured":"Kahl B, Herrmann M, Everding AS, Koch HG, Becker K, Harms E et al (1998) Persistent infection with small colony variant strains of Staphylococcus aureus in patients with cystic fibrosis. J Infect Dis 177(4):1023\u20131029","journal-title":"J Infect Dis"},{"issue":"4","key":"16_CR100","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nrmicro1384","volume":"4","author":"RA Proctor","year":"2006","unstructured":"Proctor RA, von Eiff C, Kahl BC, Becker K, McNamara P, Herrmann M et al (2006) Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections. Nat Rev Microbiol 4(4):295\u2013305","journal-title":"Nat Rev Microbiol"},{"issue":"4","key":"16_CR101","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.diagmicrobio.2017.11.012","volume":"90","author":"N Suwantarat","year":"2018","unstructured":"Suwantarat N, Rubin M, Bryan L, Tekle T, Boyle MP, Carroll KC et al (2018) Frequency of small-colony variants and antimicrobial susceptibility of methicillin-resistant Staphylococcus aureus in cystic fibrosis patients. Diagn Microbiol Infect Dis 90(4):296\u2013299","journal-title":"Diagn Microbiol Infect Dis"},{"key":"16_CR102","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.mib.2017.09.007","volume":"42","author":"L Radlinski","year":"2018","unstructured":"Radlinski L, Conlon BP (2018) Antibiotic efficacy in the complex infection environment. Curr Opin Microbiol 42:19\u201324","journal-title":"Curr Opin Microbiol"},{"issue":"6","key":"16_CR103","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1136\/thx.2008.104711","volume":"64","author":"JG Mainz","year":"2009","unstructured":"Mainz JG, Naehrlich L, Schien M, Kading M, Schiller I, Mayr S et al (2009) Concordant genotype of upper and lower airways P aeruginosa and S aureus isolates in cystic fibrosis. Thorax 64(6):535\u2013540","journal-title":"Thorax"},{"issue":"9","key":"16_CR104","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1128\/JCM.00855-07","volume":"45","author":"S Ridder-Schaphorn","year":"2007","unstructured":"Ridder-Schaphorn S, Ratjen F, Dubbers A, Haberle J, Falk S, Kuster P et al (2007) Nasal Staphylococcus aureus carriage is not a risk factor for lower-airway infection in young cystic fibrosis patients. J Clin Microbiol 45(9):2979\u20132984","journal-title":"J Clin Microbiol"},{"issue":"3","key":"16_CR105","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/alr.22067","volume":"8","author":"KJ Choi","year":"2018","unstructured":"Choi KJ, Cheng TZ, Honeybrook AL, Gray AL, Snyder LD, Palmer SM et al (2018) Correlation between sinus and lung cultures in lung transplant patients with cystic fibrosis. Int Forum Allergy Rhinol 8(3):389\u2013393","journal-title":"Int Forum Allergy Rhinol"},{"issue":"11","key":"16_CR106","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/j.healun.2012.08.012","volume":"31","author":"RK Shields","year":"2012","unstructured":"Shields RK, Clancy CJ, Minces LR, Kwak EJ, Silveira FP, Abdel Massih RC et al (2012) Staphylococcus aureus infections in the early period after lung transplantation: epidemiology, risk factors, and outcomes. J Heart Lung Transplant 31(11):1199\u20131206","journal-title":"J Heart Lung Transplant"},{"key":"16_CR107","unstructured":"Cystic Fibrosis Trust Standards for the Clinical Care of Children and Adults with Cystic Fibrosis in the UK. Cystic Fibrosis Trust"},{"issue":"10","key":"16_CR108","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1164\/rccm.200705-664OC","volume":"176","author":"PA Flume","year":"2007","unstructured":"Flume PA, O'Sullivan BP, Robinson KA, Goss CH, Mogayzel PJ Jr, Willey-Courand DB et al (2007) Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health. Am J Respir Crit Care Med 176(10):957\u2013969","journal-title":"Am J Respir Crit Care Med"},{"issue":"Suppl 1","key":"16_CR109","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1016\/j.jcf.2014.03.010","volume":"13","author":"AR Smyth","year":"2014","unstructured":"Smyth AR, Bell SC, Bojcin S, Bryon M, Duff A, Flume P et al (2014) European cystic fibrosis society standards of care: best practice guidelines. J Cyst Fibros 13(Suppl 1):S23\u2013S42","journal-title":"J Cyst Fibros"},{"issue":"3","key":"16_CR110","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/ppul.10231","volume":"36","author":"A Solis","year":"2003","unstructured":"Solis A, Brown D, Hughes J, Van Saene HK, Heaf DP (2003) Methicillin-resistant Staphylococcus aureus in children with cystic fibrosis: an eradication protocol. Pediatr Pulmonol 36(3):189\u2013195","journal-title":"Pediatr Pulmonol"},{"issue":"7","key":"16_CR111","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1164\/rccm.201207-1160OE","volume":"187","author":"PJ Mogayzel Jr","year":"2013","unstructured":"Mogayzel PJ Jr, Naureckas ET, Robinson KA, Mueller G, Hadjiliadis D, Hoag JB et al (2013) Cystic fibrosis pulmonary guidelines. Chronic medications for maintenance of lung health. Am J Respir Crit Care Med 187(7):680\u2013689","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"16_CR112","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1067\/mpd.2002.121930","volume":"140","author":"HR Stutman","year":"2002","unstructured":"Stutman HR, Lieberman JM, Nussbaum E, Marks MI (2002) Antibiotic prophylaxis in infants and young children with cystic fibrosis: a randomized controlled trial. J Pediatr 140(3):299\u2013305","journal-title":"J Pediatr"},{"key":"16_CR113","volume":"7","author":"DK Lo","year":"2018","unstructured":"Lo DK, Muhlebach MS, Smyth AR (2018) Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis. Cochrane Database Syst Rev 7:Cd009650","journal-title":"Cochrane Database Syst Rev"},{"key":"16_CR114","volume":"4","author":"AR Smyth","year":"2017","unstructured":"Smyth AR, Rosenfeld M (2017) Prophylactic anti-staphylococcal antibiotics for cystic fibrosis. Cochrane Database Syst Rev 4:CD001912","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"16_CR115","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1378\/chest.10-1556","volume":"139","author":"AJ Walkey","year":"2011","unstructured":"Walkey AJ, O'Donnell MR, Wiener RS (2011) Linezolid vs glycopeptide antibiotics for the treatment of suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a meta-analysis of randomized controlled trials. Chest 139(5):1148\u20131155","journal-title":"Chest"},{"issue":"2","key":"16_CR116","first-page":"125","volume":"23","author":"NM Fusco","year":"2018","unstructured":"Fusco NM, Meaney CJ, Wells C, Frederick CA, Prescott WA Jr (2018) Vancomycin versus vancomycin plus rifampin for the treatment of acute pulmonary exacerbations of cystic fibrosis. J Pediatr Pharmacol Ther 23(2):125\u2013131","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"4","key":"16_CR117","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1136\/thoraxjnl-2016-208949","volume":"72","author":"MS Muhlebach","year":"2017","unstructured":"Muhlebach MS, Beckett V, Popowitch E, Miller MB, Baines A, Mayer-Hamblett N et al (2017) Microbiological efficacy of early MRSA treatment in cystic fibrosis in a randomised controlled trial. Thorax 72(4):318\u2013326","journal-title":"Thorax"},{"issue":"2","key":"16_CR118","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1155\/1995\/176396","volume":"6","author":"DR Burdge","year":"1995","unstructured":"Burdge DR, Nakielna E, Noble M (1995) Eradication of methicillin-resistant Staphylococcus aureus from the lower respiratory tract of patients with cystic fibrosis. Can J Infect Dis 6(2):97\u2013101","journal-title":"Can J Infect Dis"},{"issue":"2","key":"16_CR119","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jcf.2009.11.009","volume":"9","author":"SJ Doe","year":"2010","unstructured":"Doe SJ, McSorley A, Isalska B, Kearns AM, Bright-Thomas R, Brennan AL et al (2010) Patient segregation and aggressive antibiotic eradication therapy can control methicillin-resistant Staphylococcus aureus at large cystic fibrosis centres. J Cyst Fibros 9(2):104\u2013109","journal-title":"J Cyst Fibros"},{"issue":"3","key":"16_CR120","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.jhin.2003.12.003","volume":"56","author":"LA Garske","year":"2004","unstructured":"Garske LA, Kidd TJ, Gan R, Bunting JP, Franks CA, Coulter C et al (2004) Rifampicin and sodium fusidate reduces the frequency of methicillin-resistant Staphylococcus aureus (MRSA) isolation in adults with cystic fibrosis and chronic MRSA infection. J Hosp Infect 56(3):208\u2013214","journal-title":"J Hosp Infect"},{"key":"16_CR121","unstructured":"Wilkinson JD (2008) MRSA in Paediatric Cystic Fibrosis patients, Eradication and Treatment. \n                  http:\/\/www.clinicalguidelines.scot.nhs.uk\/ggc-paediatric-guidelines\/ggc-guidelines\/microbiology\/mrsa-in-paediatric-cystic-fibrosis-patients-eradication-and-treatment\/\n                  \n                . Accessed 26 Oct 2018"},{"issue":"4","key":"16_CR122","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/S0022-3476(79)80785-4","volume":"95","author":"VA Loening-Baucke","year":"1979","unstructured":"Loening-Baucke VA, Mischler E, Myers MG (1979) A placebo-controlled trial of cephalexin therapy in the ambulatory management of patients with cystic fibrosis. J Pediatr 95(4):630\u2013637","journal-title":"J Pediatr"},{"key":"16_CR123","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/1469-0691.12450","volume":"20","author":"J Chastre","year":"2014","unstructured":"Chastre J, Blasi F, Masterton RG, Relio J, Torres A, Welte T (2014) European perspective and update on the management of nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus after more than 10 years of experience with linezolid. Clin Microbiol Infect 20:19\u201336","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl 2","key":"16_CR124","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1086\/511159","volume":"44","author":"LA Mandell","year":"2007","unstructured":"Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, Dowell SF, File JTM, Musher DM, Niederman MS, Torres A, Whitney CG (2007) Infectious Diseases Society of America\/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults. Clin Infect Dis 44(Suppl 2):S27\u2013S72","journal-title":"Clin Infect Dis"},{"issue":"9","key":"16_CR125","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00956-18","volume":"62","author":"M Roch","year":"2018","unstructured":"Roch M, Varela MC, Taglialegna A, Rose WE, Rosato AE (2018) Activity of telavancin against Staphylococcus aureus isolates, including those with decreased susceptibility to ceftaroline, from cystic fibrosis patients. Antimicrob Agents Chemother 62(9):e00956-18","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"16_CR126","first-page":"1233","volume":"33","author":"M Shirai","year":"1995","unstructured":"Shirai M, Ide K, Sato M, Murakami M, Tanaka Y, Sato A et al (1995) Effect of inhaled vancomycin hydrochloride on elimination of methicillin-resistant Staphylococcus aureus. Nihon Kyobu Shikkan Gakkai Zasshi 33(11):1233\u20131239","journal-title":"Nihon Kyobu Shikkan Gakkai Zasshi"},{"issue":"10","key":"16_CR127","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1002\/ppul.23519","volume":"51","author":"M Kappler","year":"2016","unstructured":"Kappler M, Nagel F, Feilcke M, Kr\u00f6ner C, Pawlita I, Naehrig S et al (2016) Eradication of methicillin resistant Staphylococcus aureus detected for the first time in cystic fibrosis: a single center observational study. Pediatr Pulmonol 51(10):1010\u20131019","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"16_CR128","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/j.1440-1843.2009.01647.x","volume":"15","author":"D Hayes Jr","year":"2010","unstructured":"Hayes D Jr, Murphy BS, Mullett TW, Feola DJ (2010) Aerosolized vancomycin for the treatment of MRSA after lung transplantation. Respirology 15(1):184\u2013186","journal-title":"Respirology"},{"key":"16_CR129","unstructured":"Patrick FA (2018) Phase III, randomized, double-blind, placebo-controlled study of AeroVanc for the treatment of persistent methicillin-resistant Staphylococcus Aureus lung infection in cystic fibrosis patients. Accessed 5 Nov 2018"},{"issue":"8","key":"16_CR130","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1002\/ppul.23707","volume":"52","author":"ET Zemanick","year":"2017","unstructured":"Zemanick ET, Daines CL, Dellon EP, Esther CR Jr, Kinghorn B, Ong T et al (2017) Highlights from the 2016 north American cystic fibrosis conference. Pediatr Pulmonol 52(8):1103\u20131110","journal-title":"Pediatr Pulmonol"},{"issue":"6","key":"16_CR131","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1002\/ppul.23132","volume":"50","author":"JT Zobell","year":"2015","unstructured":"Zobell JT, Epps KL, Young DC, Montague M, Olson J, Ampofo K et al (2015) Utilization of antibiotics for methicillin-resistant Staphylococcus aureus infection in cystic fibrosis. Pediatr Pulmonol 50(6):552\u2013559","journal-title":"Pediatr Pulmonol"},{"issue":"7","key":"16_CR132","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1513\/AnnalsATS.201402-050AS","volume":"11","author":"JF Chmiel","year":"2014","unstructured":"Chmiel JF, Aksamit TR, Chotirmall SH, Dasenbrook EC, Elborn JS, LiPuma JJ et al (2014) Antibiotic management of lung infections in cystic fibrosis. I. the microbiome, methicillin-resistant Staphylococcus aureus, gram-negative bacteria, and multiple infections. Ann Am Thorac Soc 11(7):1120\u20131129","journal-title":"Ann Am Thorac Soc"}],"container-title":["Methods in Molecular Biology","Methicillin-Resistant Staphylococcus Aureus (MRSA) Protocols"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-9849-4_16","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,15]],"date-time":"2019-09-15T12:02:32Z","timestamp":1568548952000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-9849-4_16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,16]]},"ISBN":["9781493998487","9781493998494"],"references-count":132,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-9849-4_16","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,16]]},"assertion":[{"value":"16 September 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}